Nymox Pharmaceutical Corp
NYMX
NYMX was delisted on the 6th of July, 2023.
29 hedge funds and large institutions have $7.24M invested in Nymox Pharmaceutical Corp in 2014 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 7 closing their positions.
122% more call options, than puts
Call options by funds: $507K | Put options by funds: $228K
17% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 6
3% more capital invested
Capital invested by funds: $7.03M → $7.24M (+$214K)
6% less funds holding
Funds holding: 31 → 29 (-2)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAM
Advisors Asset Management
Monument,
Colorado
|
+$1.19M |
| 2 |
Millennium Management
New York
|
+$111K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$102K |
| 4 |
WB
Webster Bank
Waterbury,
Connecticut
|
+$96.3K |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
+$88.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$586K |
| 2 |
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO)
Irvine,
California
|
-$383K |
| 3 |
Renaissance Technologies
New York
|
-$139K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$134K |
| 5 |
DDC
DF Dent & Co
Baltimore,
Maryland
|
-$111K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
U
26
UBS
Zurich,
Switzerland
| $6K | -$3.36K | -686 | -33% |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| $6K | +$6.99K | +1,426 | New |
|
28
ClearBridge Investments
New York
| $4K | – | – | – |
|
29
Creative Planning
Overland Park,
Kansas
| $4K | – | – | – |
|
|
PAAMCP
30
Pacific Alternative Asset Management Company (PAAMCO)
Irvine,
California
| – | -$383K | -77,466 | Closed |
|
|
31
Renaissance Technologies
New York
| – | -$139K | -28,000 | Closed |
|
|
32
Northern Trust
Chicago,
Illinois
| – | -$134K | -27,050 | Closed |
|
|
DDC
33
DF Dent & Co
Baltimore,
Maryland
| – | -$111K | -22,500 | Closed |
|
|
WAM
34
Wolverine Asset Management
Chicago,
Illinois
| – | -$16K | -3,400 | Closed |
|
|
PCM
35
Prelude Capital Management
New York
| – | -$13K | -2,560 | Closed |
|
|
GSC
36
Ground Swell Capital
Folly Beach,
South Carolina
| – | -$1K | -202 | Closed |
|
NYMX Hedge Fund Activity: Q3 2014 in Review
29 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q3 2014, worth a combined $7.24M — up 3% from $7.03M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of NYMX and 5 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 7 added.
The largest buyer was Advisors Asset Management, adding an estimated $1.19M. The largest seller was Canada Pension Plan Investment Board, cutting an estimated $586K.
- 29 institutional investors held Nymox Pharmaceutical Corp (NYMX) as of Q3 2014, down from 31 in Q2 2014.
- Funds reported $7.24M of Nymox Pharmaceutical Corp stock for Q3 2014, up 3% quarter-over-quarter.
- 5 funds opened new Nymox Pharmaceutical Corp positions in Q3 2014 and 7 closed out, a net change of -2 holders.
- The largest Nymox Pharmaceutical Corp buyer in Q3 2014 was Advisors Asset Management, an estimated $1.19M added.
- The largest Nymox Pharmaceutical Corp seller in Q3 2014 was Canada Pension Plan Investment Board, an estimated $586K sold.
Based on aggregated 13F filings for Q3 2014.